250
Participants
Start Date
August 15, 2024
Primary Completion Date
August 15, 2027
Study Completion Date
August 15, 2027
Height, weight, and BMI
Height, weight measurement and BMI calculation
Medical history
Brief medical history including medications/allergies and heart failure related healthcare utilisation over previous 12 months
Physical examination
Brief physical examination
Venous blood samples
Venous blood samples, to include WCC, HB, CRP and NTproBNP
Resting vital signs
HR, BP, RR, oxygen saturations on air)
Transthoracic echocardiogram
LVEF, IVC collapsibility, LV filling pressure, PA pressure
Sound recordings
Sound recordings (voice/cough/chest) recorded with the in-built microphone in a smartphone
Lung ultrasound
Lung ultrasound
KCCQ questionnaire
Kansas City Cardiomyopathy Questionnaire
ASCEND-HF score
An in-hospital congestion score which risk stratifies patients admitted with worsening heart failure, developed for the Acute study of clinical effectiveness of Nesiritide in decompensated heart failure trial
Composite Everest congestion score
A shortened version of the original 18-point score from the EVEREST trial
Bio impedance and total body water measurement
Bio impedance and total body water measurement using TANITA device
University of Cambridge
OTHER
Cambridge University Hospitals NHS Foundation Trust
OTHER